On the basis of the International Neuroblastoma Risk Group (INRG) classification system incorporating patient age at diagnosis, INSS stage, DNA ploidy status, MYCN status, and tumor histopathology, NB patients can be classified into three risk groups (low, intermediate, and high risk) and individually treated based on stratification [4]. The gene discussed is MYCN; the disease is neuroblastoma.